Frontiers in Immunology
A neuroimmune-enriched multibiofluid proteomic index associated with cognitive-motor progression in early Parkinson's disease: a longitudinal PPMI cohort study
Cohort study of 521 peopleBiomarkers
Abstract
Progression in early Parkinson's disease (PD) is heterogeneous, motivating transparent biological markers of group-level progression context. We analyzed longitudinal Parkinson's Progression Markers Initiative (PPMI) data downloaded on 31 May 2026.
The paper
Henan University of Science and Technology
Frontiers in Immunology, 14 Sep 2026, CC BY
